
CCSI Stock Forecast & Price Target
CCSI Analyst Ratings
Bulls say
Consensus Cloud Solns is expected to continue its positive growth momentum as its corporate channel saw a growth of 9.3% y/y and the VA contract is expected to contribute over $9M+ revenue in 2026E, while also launching new mobile capabilities in the healthcare space. CCSI's strong focus in the healthcare sector, with ~60%+ of its corporate revenue coming from this industry, combined with its advanced integrated solutions tailored to specific customer needs and its well-managed debt, makes it a strong contender in the market. Additionally, its expansion into the government sector and new product offerings through in-house R&D also present potential growth opportunities.
Bears say
Consensus Cloud Solns is overvalued, trading at 6x 2027E EBITDA and a premium to its sub-sector average. The company's business model is strong, and its continuous addition of solutions to its platform expands its total addressable market. However, its limited trading history, small cap status, and slower growth compared to SaaS peers, coupled with inflationary pressures and labor constraints in the healthcare market, pose risks for future performance. Additionally, its high retention rate of ~99% and focus on debt reduction and buybacks are positive factors but may not be enough to justify its current valuation.
This aggregate rating is based on analysts' research of Consensus Cloud Solutions and is not a guaranteed prediction by Public.com or investment advice.
CCSI Analyst Forecast & Price Prediction
Start investing in CCSI
Order type
Buy in
Order amount
Est. shares
0 shares